We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cambridge Cognition Holdings Plc | LSE:COG | London | Ordinary Share | GB00B8DV9647 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 52.00 | 51.00 | 53.00 | 52.00 | 52.00 | 52.00 | 3,759 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 12.61M | -409k | -0.0117 | -44.44 | 18.12M |
Date | Subject | Author | Discuss |
---|---|---|---|
07/6/2017 09:45 | FinnCap restated their corporate rating on shares of Cambridge Cognition Holdings PLC (LON:COG) in a research note published on Tuesday morning. They currently have a GBX 130 ($1.67) price objective on the stock. | jamesd888 | |
07/6/2017 09:38 | Cambridge Cognition Holdings Plc ('Cambridge Cognition' or the 'Company') Speech recognition for clinical trials Cambridge Cognition Holdings PLC (Cambridge, UK - LSE: COG, 'Company'), the neuroscience digital health company, is pleased to announce its application of automatic speech recognition ("ASR") technology to develop new products to enable scalable, language-based clinical assessment to reduce clinical trial variability and costs and increase overall clinical trial efficiency. The Company is now employing commercially available Artificial Intelligence ("AI") and ASR technologies to make language-based verbal cognitive assessments that are scalable, automated and consistent, which in turn will reduce human error between trial centres and between trial subjects. The first products are expected to be available commercially in mid 2018. Language is a unique human capability that exhibits measurable changes in many psychiatric and neurological conditions including Alzheimer's disease, depression and schizophrenia. To date it has been difficult for clinical researchers to perform language-based assessments or measure verbal cognitive changes without highly trained experts. Now this new combination of speech recognition technology with Cambridge Cognition's validated computerised tests will make this possible. This new platform, powered by AI, will allow innovative types of language-based cognitive assessment raising the possibility of delivering clinician-administer The Company's ASR-based technology will be unveiled formally at the Alzheimer's Association Technology and Dementia preconference in London on July 15 2017, where data from a proof of concept study will be presented. | jamesd888 | |
07/6/2017 09:15 | Up 5 percent now....hold on to your hats | jamesd888 | |
07/6/2017 08:58 | Great RNS today | jamesd888 | |
07/6/2017 08:52 | Expect this COG to grow rapidly this year | jamesd888 | |
30/5/2017 16:11 | Wrong thread? | oliversanvil | |
30/5/2017 15:32 | Punters charging for the exits. Always best to sell these illiquid tiddlers when they are tipped and buy back when the euphoria has abated. | phowdo | |
22/5/2017 09:25 | mental health treatment set to double...expect COG to be £9.00 by the end of the year....the next move upwards will be pretty fast...buy now before this blows | jamesd888 | |
10/5/2017 10:51 | up 1% now.....are we gonna close around 1.50 today | jamesd888 | |
10/5/2017 09:49 | Company looking after employees...Well worth buying | jamesd888 | |
09/5/2017 10:05 | This is going heading over £2.00 and once they get FDA this will fly to £4.00 news expected very soon | jamesd888 | |
05/5/2017 16:26 | Cognition Kit deal...looking forward to Monday | jamesd888 | |
05/5/2017 15:59 | This is under the radar and about to fly | jamesd888 | |
05/5/2017 15:58 | looking forward to next week | jamesd888 | |
05/5/2017 15:37 | COG new contract deal....hold on to your hats...news not out....could hit £2.00 soon | jamesd888 | |
21/4/2017 10:12 | Apologies. COG is listed in today's issue as one of Simon Thompson's recent articles (page 15), but it seems his very full analysis remains for internet subscribers only. For now anyway. | hew | |
20/4/2017 16:17 | Will be on newsagent's shelves on Friday. | hew | |
19/4/2017 23:42 | That wouldn't be fair to paying subscribers it's only around £28 per quarter to sign up | spob | |
19/4/2017 15:07 | Come guys and gals somebody post the article please | pgaffney | |
19/4/2017 13:16 | anyone able to share a synopsis of at what he said | janeann | |
19/4/2017 12:39 | The Simon Thompson (IC) effect | gersemi | |
19/4/2017 12:21 | i'm only going on the past with these, spikes often give way to selling. only my opinion... | targatarga | |
19/4/2017 12:17 | thanks....... | janeann | |
19/4/2017 12:15 | just dumped my 25k at 102, tipped in ic apparently. | targatarga |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions